SCHEMBL6183097

SCHEMBL6183097

C=Cc1ncc(Cl)cc1C

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDXK O00764 1/20 0.36
HTT P42858 3/20 0.32
NPC1 O15118 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 2/20 0.32
HPGD P15428 1/20 0.32
ALDH1A1 P00352 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
LMNA P02545 1/20 0.31
PABPC1 P11940 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2083207 0.79 HTT (0.35) HTTNPC1GAAMAPTRAB9A
SCHEMBL7245034 0.78 NOS3 (0.46) PDXKCYP1A2
SCHEMBL1138039 0.78 SMN1; SMN2 (0.39) PDXKHTTNPC1GAAMAPT
SCHEMBL30224739 0.75 MAPT (0.32) HTTMAPTHSD17B10ALDH1A1
SCHEMBL18688147 0.75 RRM2 (0.37) PDXKALDH1A1
SCHEMBL17688337 0.75 PLAU (0.42) PDXK
SCHEMBL19823644 0.75 AGBL2 (0.41) PDXK
SCHEMBL15991301 0.75 PDXK (0.43) PDXKMAPTALDH1A1MEN1KMT2A
SCHEMBL17688294 0.75 IDO1 (0.35) SMN1; SMN2HSD17B10HPGDALDH1A1CYP3A4
SCHEMBL24011728 0.75 ESR2 (0.47) NPC1MAPTRAB9ASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501805-A1 SUBSTITUTED PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2005-02-02 EP disclosed
WO-2003095430-A1 SUBSTITUTED PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2003-11-20 WO disclosed